CAPR - CAPRICOR THERAPEUTICS, INC.
IEX Last Trade
12.72
0.220 1.730%
Share volume: 745,175
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$12.50
-0.47
-0.04%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-14 | 2023-08-08 | 2023-11-14 | 2024-11-14 | 2024-05-14 | 2024-08-08 | 2024-11-14 | |
| Total revenue | 2.987 M | 3.917 M | 6.186 M | 12.088 M | 4.907 M | 3.971 M | 2.262 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 2.987 M | 3.917 M | 6.186 M | 12.088 M | 4.907 M | 3.971 M | 2.262 M | |
| 31.16% | 57.90% | 95.42% | -59.41% | -19.06% | -43.05% | |||
| Operating expenses | 11.171 M | 11.665 M | 13.050 M | 13.369 M | 15.173 M | 15.563 M | 15.272 M | |
| Selling general and admin | 3.510 M | 2.847 M | 3.021 M | 3.429 M | 4.072 M | 3.058 M | 3.464 M | |
| Research and development | 7.662 M | 8.817 M | 10.029 M | 9.940 M | 11.101 M | 12.505 M | 11.808 M | |
| Total expenses | 11.171 M | 11.665 M | 13.056 M | 13.375 M | 15.173 M | 15.563 M | 15.272 M | |
| 4.42% | 11.93% | 2.45% | 13.44% | 2.57% | -1.87% | |||
| Operating income | -8.185 M | -7.747 M | -6.865 M | -1.281 M | -10.266 M | -11.591 M | -13.010 M | |
| Ebit | -8.185 M | -7.747 M | -6.865 M | -1.281 M | -10.266 M | -11.591 M | -13.010 M | |
| Pretax income | -7.768 M | -7.367 M | -6.385 M | -761.436 K | -9.794 M | -11.000 M | -12.557 M | |
| -5.17% | -13.32% | -88.08% | 1,186.26% | 12.31% | 14.15% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -7.768 M | -7.367 M | -6.391 M | -762.089 K | -9.794 M | -11.000 M | -12.557 M | |
| 5.17% | 13.25% | 88.07% | -1,185.16% | -12.31% | -14.15% |